Podcasts about Diabetic foot

Dean's Chat host - Dr. Jeffrey Jensen, was asked to moderate a session with four of the leading Diabetic Foot speicalists in the world, all with common roots back to the University of Texas - San Antonio.   This episode is sponsored by Bako Diagnostics! Dr. Jensen welcomes Dr. Lawrence Harkless, Dr. David Armstrong, Dr. Lawrence Lavery, and Dr. John Steinberg! This episode is a little different; it's a slice of history, it's about relationships,  it's about mentorship, leadership, the mentor/mentee relationship, paving paths in academic heath centers, collaborative efforts to expand research, discussing a profession that leads to multigenerations of podiatrists!    So much to talk about and so little time!  Enjoy! https://bakodx.com/ https://bmef.org/ www.explorepodmed.org https://podiatrist2be.com/  

AOTI Inc (AIM:AOTI) CEO, president, and co-founder Dr Mike Griffiths talked with Proactive about the company's efforts to revolutionise chronic wound care. AOTI is focused on treating conditions like diabetic foot ulcers with its unique home-based oxygen therapy, designed to promote durable healing. Griffiths highlighted the staggering $80 billion US diabetic foot ulcer care market and shared that AOTI is well-positioned to expand within this space. He noted that AOTI's strong clinical evidence and ability to reduce hospitalisations and amputations resonate strongly with payers and healthcare providers. He also shared recent milestones, including the company's expansion into six Medicaid states, its five-year renewal of the Veterans Affairs contract, and ongoing efforts to broaden its international presence. Griffiths announced the start of enrolments for the venous leg ulcer (VLU) clinical trial and discussed its significance in building high-quality evidence for AOTI's therapy. AOTI, headquartered in the US and listed on AIM, has grown by over 30% annually for five years and Griffiths expects this growth to continue as it enters new markets like skilled nursing and long-term care. “We believe we're in a very exciting sector, with solutions that deliver long-term outcomes,” he shared. Visit Proactive's YouTube channel for more videos, and don't forget to like, subscribe, and enable notifications for updates! #AOTI #ChronicWoundCare #DiabeticFootUlcers #MedicalTechnology #HealthcareInnovation #OxygenTherapy #Medicaid #VeteransAffairs #ClinicalTrials #MedTechGrowth

Join us as Monee and Meredith with the rest of the hospital medicine team reflect on the past year, discussing some favorite insights gained covering a range of topics, including diabetic foot infections, sepsis, sickle cell inpatient management, syncope, psychiatry for the hospitalist, and acute coronary syndrome.  No CME for this episode, but claim CME for past shows at curbsiders.vcuhealth.org! Patreon | Episodes | Subscribe | Spotify | YouTube | Newsletter | Contact | Swag! | CME Show Segments Introduction Picks of the Year Diabetic Foot Infections  Sepsis Sickle Cell Inpatient Management  Psychiatry Primer Syncope  Acute Coronary Syndrome  Reflections from the Year  Credits Written, Produced, and hosted by: Meredith Trubitt  MD; Monee Amin MD Script Written: Caroline Coleman, MD, RJ Blackburn, MD Cover Art: Caroline Coleman, MD Reviewer: Rahul Ganatra MD Showrunners: Matthew Watto MD, FACP; Paul Williams MD, FACP Technical Production: PodPaste Sponsor: Rosetta Stone Redeem your 50% off at rosettastone.com/curbsiders

Dr. Burns earned his bachelor's degree from the University of Pittsburgh, graduating with honors in biological sciences. He then graduated summa cum laude from the Dr. William M. Scholl College of Podiatric Medicine in Chicago. He returned to the University of Pittsburgh to complete his surgical residency, and joined the Foot and Ankle Division of the University of Pittsburgh Department of Orthopedic Surgery where he worked for 17 years before recently joining West Virginia University Medicine as part of their foot and ankle reconstructive team.  Join us as we discuss all things podiatric medicine as we talk with Dr. Burns about his experience educating students, residents and fellows. He has written and lectured extensively regarding External fixation and Charcot neuroarthropathy as well as issues related to the diabetic foot. Tune in as we discuss his Fellowship in Kurgan Russia as well as his role as Co-Chair of the International External fixation Symposium.    Dr. Burns also participates in local, state, and national committees and associations and has been named to the “Most Influential” DPM's across the country twice and has been given the “Distinguished Service Award” by the Pennsylvania Podiatric Medical Association for his work in education. He is considered a thought leader within the profession and has served in various leadership positions including medical director for UPMC Mercy Hospital. Listen in, as he describes the importance of relationship building and how trying to be 1% better each day can translate into future opportunities.  Dr. Burns is board certified in foot surgery and reconstructive rearfoot and ankle surgery. He is a member of the American Podiatric Medical Association and a diplomate of the American Board of Foot and Ankle Surgery. Dr. Burns is the Associate Editor of the surgical section of the Journal of the American Podiatric Medical Association, Clinics of Podiatric Medicine and Surgery and the Foot and Ankle Specialist He also has served on the editorial board of several other publications including UpToDate, and functioned as the Editor in chief for Diabetic Foot and Ankle. His interests include complex foot and ankle deformity and preservation techniques. He has extensive experience with complex foot and ankle surgery, revision surgery, trauma and fracture care, Charcot neuroarthropathy and limb preservation.  https://wvumedicine.org/wheeling/education/podiatric-medicine-and-surgery-residency/ https://www.acfas.org/ https://www.abfas.org/residents https://www.aofoundation.org/aona https://www.apma.org/  

In this episode, host Seth O'Brien, CP, FAAOP(D), talks with Dr. Rory Gilhooly, a podiatric physician at Community Podiatry Group in Flint, MI, about diabetic foot health in O&P care. They discuss orthotic interventions for diabetic foot management, highlighting the importance of carefully monitoring inserts and footwear to prevent complications. Dr. Gilhooly shares insights on surgical options for managing diabetic foot issues and emphasizes the value of regular follow-ups to catch early warning signs, such as calluses or infections. The conversation also underscores the essential collaboration between podiatrists and prosthetists to provide the best patient outcomes.   O&P Clinical Care Insiders is produced by Association Briefings.

Diabetes-related foot conditions like ulcers and amputations can be very serious, but these complications are preventable when comprehensive foot exams are prioritized. Podiatrist Dr. Mark Hinkes joined The Huddle to talk about the importance of foot health and comprehensive foot exams for people with diabetes, and how we can use data collected from these foot exams to predict potential future risk. Learn more about the International Working Group on the Diabetic Foot here: Home - IWGDF GuidelinesView Mark's book "Healthy Feet for People with Diabetes" here: Healthy Feet for People With Diabetes: Hinkes DPM, Dr. Mark: 9780985628604: Books - Amazon.caLearn more about diabetes-related foot complications:Foot Complications | ADAFive year mortality and direct costs of care for people with diabetic foot complications are comparable to cancer | Journal of Foot and Ankle Research | Full Text Listen to more episodes of The Huddle at adces.org/perspectives/the-huddle-podcast.Learn more about ADCES and the many benefits of membership at adces.org/join.

Dean's Chat hosts Drs. Jeffrey Jensen and Johana Richey are joined by Dr. Lawrence Lavery, a world authority in researching the Diabetic Foot, and a member of the International Working Group on the Diabetic Foot. Today's discussion is fascinating, as we delve into the mindset, idea generation, priorities, personality and inquisitiveness that have enabled Dr. Lavery, over the past 30 years, to be a world expert in researching the diabetic foot.   Lawrence A. Lavery is transitioning to a new role to enhance his incredible research career, A former Professor in the Department of Plastic Surgery, as well as Director of Clinical Research, at the University of Texas Southwestern Medical Center, he is now moving to the University of Texas, San Antonio.  His research group has published 320 peer reviewed papers and has received extramural funding from the Veterans Administration, National Institute of Health, Agency for Healthcare Research and Quality, American Diabetes Association, and the American College of Foot and Ankle Surgeons.     Dr. Lavery's H-Index is 108.  This means that Dr. Lavery has 108 publications that have each been sited over 108 times in other peer reviewed papers. To put this into perspective, Nobel prize winners have H-Indexes of less than 70!  Wow!  Enjoy!   https://iwgdfguidelines.org/lavery/ https://deanschat.com/ https://bakodx.com/ https://bmef.org/ www.explorepodmed.org

In the April episode of Critical Decisions in Emergency Medicine, Drs. Danya Khoujah and Wendy Chang discuss pediatric seat belt injuries and diabetic foot infections. As always, you'll hear about the hot topics covered in CDEM's regular features, including septic shock caused by a perforated appendix in Clinical Pediatrics, chronic cervical myelopathy following a fall in Orthopedics and Trauma, stopping intra-oral bleeding post dental extraction in The Critical Procedure, palliative care in the LLSA Literature Review, and sudden-onset leg pain in The Critical Image.

PodChatLive 131: Determinants of diabetic foot complications & a new review on non-surgical management of big toe arthritis Contact us: getinvolved@podchatlive.com Links from this week: Italian Olympian breaks high-jump record before faking injury, jokingly pulling springs from shoe What are the most effective treatments for arthritis of the big toe, excluding surgery? The Risk of the Aggravation of Diabetic Foot According to Air Quality Factors in the Republic of Korea Correlation between time in range and diabetic foot in patients with type 2 diabetes mellitus Want stronger, toned calves? Introducing the Muscle Runner

Guest: Peter Kurz, Wound Management Nurse Specialist Host: Andrea Culshaw, Global Director Professional Affairs, Mölnlycke Health Care The views, information, and/or opinions expressed in this podcast are solely those of the individuals involved and do not necessarily represent those of Mölnlycke Health Care (“Mölnlycke”). Mölnlycke is not responsible and does not verify the accuracy of any of the information contained in this podcast. The information presented is solely for informational and educational purposes. The presentation may contain information on Mölnlycke's products, educational content and/or demonstrate certain techniques used by the guest speaker. However, Mölnlycke does not provide any medical advice and this podcast shall thus not be perceived as a medical advice.  Promotion of Mölnlycke's products is to be on-label and consistent with approved indications and intended uses. For detailed device information, including indications for use, contraindications, effects, precautions and warnings, please consult the product's Instructions for Use (IFU) prior to use. This presentation and the information presented may not be appropriate for all jurisdictions. The guest(s) are paid consultants of Mölnlycke.

Guest: José Luis Lázaro-Martínez, Professor Host: Andrea Culshaw, Global Director Professional Affairs, Mölnlycke Health Care The views, information, and/or opinions expressed in this podcast are solely those of the individuals involved and do not necessarily represent those of Mölnlycke Health Care (“Mölnlycke”). Mölnlycke is not responsible and does not verify the accuracy of any of the information contained in this podcast. The information presented is solely for informational and educational purposes. The presentation may contain information on Mölnlycke's products, educational content and/or demonstrate certain techniques used by the guest speaker. However, Mölnlycke does not provide any medical advice and this podcast shall thus not be perceived as a medical advice.  Promotion of Mölnlycke's products is to be on-label and consistent with approved indications and intended uses. For detailed device information, including indications for use, contraindications, effects, precautions and warnings, please consult the product's Instructions for Use (IFU) prior to use. This presentation and the information presented may not be appropriate for all jurisdictions. The guest(s) are paid consultants of Mölnlycke.

PodChatLive 126: Swearing with patients in clinic, foot strength not reducing running injury risk, and the mediterranean diet & diabetic foot ulcers Contact us: getinvolved@podchatlive.com Links from this episode: Can Swearing Be Professional and Patient-Centered? Hip and core exercise programme prevents running-related overuse injuries in adult novice recreational runners Outrunning the grim reaper: longevity of the first 200 sub-4 min mile male runners Exploring the influence of dietary habits on foot risk in type 2 diabetes patients

In today's episode, Dr. Rachael Forsythe (@ROForsythe), consultant vascular surgeon at NHS Lothian, leads a fictional case-based discussion with leaders in managing diabetic foot ulcers. Joining the conversation are Professor Andrew Boulton, Mr. Patrick Coughlin, Dr. David Armstrong, Dr. Dane Wukich, and Dr. Edgar Peters. Professor Boulton is a professor of medicine at Manchester University in England and is co-chair of the Malvern  Diabetic Foot Conference meeting. He served as president of numerous distinguished societies, including the International Diabetes Federation. Dr.  Coughlin (@Coughlin_pa) is a consultant vascular surgeon in Leeds, England. He is a very active member of the Vascular Society of Great Britain and Ireland Council and has a special academic and clinical interest in peripheral artery disease. Dr. Armstrong (@DGArmstrong) is a podiatric surgeon and professor of surgery at Keck School of Medicine of the University of California and director of the Southwestern Academic Limb Salvage Alliance. Dr. Armstrong is very well known for his work on amputation prevention, the diabetic foot and wound healing. Dr. Wukich (@DaneWukich) is a professor and chair of the Department of Orthopedics at the University of Texas, Southwestern and Medical Director of Orthopedic Surgery at UT Southwestern University Hospitals. Dr. Wich has an interest in foot and ankle surgery, including the management of diabetes-related complications. Dr. Edgar Peters is an associate professor of internal medicine, infectious diseases, and acute medicine at Amsterdam University Medical Centers, Dr. Peter's main interest is infection of the musculoskeletal system, particularly in patients with diabetes and is the Scientific Secretary of the International Symposium on the Diabetic Foot.    Malvern Diabetic Foot Conference info: https://www.facebook.com/MalvernDiabeticFootConference/ https://eu.eventscloud.com/website/8151/   If this episode was of interest to you, please take a listen to this Transatlantic Series episode where we speak with the authors of the SVS, ESVS, and IWGDFU joint guidelines on the management of peripheral arterial disease (PAD) in patients with diabetes.    Articles, resources, and societies referenced in the episode: DF Blog. “Oral Is the New IV. Challenging Decades of Blood and Bone Infection Dogma: A Systematic Review @bradspellberg @lacuscmedcenter @usc,” January 1, 2022. https://diabeticfootonline.com/2022/01/01/oral-is-the-new-iv-challenging-decades-of-blood-and-bone-infection-dogma-a-systematic-review-bradspellberg-lacuscmedcenter-usc/. Gariani, Karim, Truong-Thanh Pham, Benjamin Kressmann, François R Jornayvaz, Giacomo Gastaldi, Dimitrios Stafylakis, Jacques Philippe, Benjamin A Lipsky, and Lker Uçkay. “Three Weeks Versus Six Weeks of Antibiotic Therapy for Diabetic Foot Osteomyelitis: A Prospective, Randomized, Noninferiority Pilot Trial.” Clinical Infectious Diseases 73, no. 7 (October 5, 2021): e1539–45. https://doi.org/10.1093/cid/ciaa1758. Li, Ho-Kwong, Ines Rombach, Rhea Zambellas, A. Sarah Walker, Martin A. McNally, Bridget L. Atkins, Benjamin A. Lipsky, et al. “Oral versus Intravenous Antibiotics for Bone and Joint Infection.” New England Journal of Medicine 380, no. 5 (January 31, 2019): 425–36. https://doi.org/10.1056/NEJMoa1710926. Magliano, Dianna, and Edward J. Boyko. IDF Diabetes Atlas. 10th edition. Brussels: International Diabetes Federation, 2021. Østergaard, Lauge, Mia Marie Pries-Heje, Rasmus Bo Hasselbalch, Magnus Rasmussen, Per Åkesson, Robert Horvath, Jonas Povlsen, et al. “Accelerated Treatment of Endocarditis—The POET II Trial: Ration ale and Design of a Randomized Controlled Trial.” American Heart Journal 227 (September 2020): 40–46. https://doi.org/10.1016/j.ahj.2020.05.012. Price, Patricia. “The Diabetic Foot: Quality of Life.” Clinical Infectious Diseases 39 (2004): S129–31. Sharma, S., C. Kerry, H. Atkins, and G. Rayman. “The Ipswich Touch Test: A Simple and Novel Method to Screen Patients with Diabetes at Home for Increased Risk of Foot Ulceration.” Diabetic Medicine: A Journal of the British Diabetic Association 31, no. 9 (September 2014): 1100–1103. https://doi.org/10.1111/dme.12450. Shin, Laura, Frank L. Bowling, David G. Armstrong, and Andrew J.M. Boulton. “Saving the Diabetic Foot During the COVID-19 Pandemic: A Tale of Two Cities.” Diabetes Care 43, no. 8 (August 1, 2020): 1704–9. https://doi.org/10.2337/dc20-1176. Tone, Alina, Sophie Nguyen, Fabrice Devemy, Hélène Topolinski, Michel Valette, Marie Cazaubiel, Armelle Fayard, Éric Beltrand, Christine Lemaire, and Éric Senneville. “Six-Week Versus Twelve-Week Antibiotic Therapy for Nonsurgically Treated Diabetic Foot Osteomyelitis: A Multicenter Open-Label Controlled Randomized Study.” Diabetes Care 38, no. 2 (February 1, 2015): 302–7. https://doi.org/10.2337/dc14-1514. Wukich, Dane K., Katherine M. Raspovic, and Natalie C. Suder. “Patients With Diabetic Foot Disease Fear Major Lower-Extremity Amputation More Than Death.” Foot & Ankle Specialist 11, no. 1 (February 2018): 17–21. https://doi.org/10.1177/1938640017694722.

Dr. Beasley teaches on diabetic foot disease

PodChatLive 115: Treadmill familiarisation, diabetic foot ulcers & antidepressants, health seeking behaviour after being in a study, and running alone Vs running with others Message us on: getinvolved@podchatlive.com In this episode: Trump Sneakers' Red Soles Risk Louboutin Trademark Infringement Association between antidepressants and the risk of diabetic foot ulcers and amputation in antidepressant-naïve type 2 diabetes mellitus patients Time to stability of treadmill running kinematics in novel footwear with different midsole thickness Does children's healthcare seeking change after participation in a musculoskeletal study? Running together influences where you look

Welcome to the Transatlantic Series, a co-production of Audible Bleeding (a publication of the SVS) and the ESVS podcast. In today's episode, we explore the intersocietal guidelines on peripheral arterial disease in patients with diabetes and foot ulcers authored by the International Working Group on the Diabetic Foot, the European Society for Vascular Surgery, and the Society for Vascular Surgery.Dr. Robert Fitridge is a Professor of Vascular Surgery at University of Adelaide in Australia. He is a member of the IWGDF and a member of the steering committee for the Global Vascular Guideline on the management of Chronic Limb-threatening Ischaemia. Dr. Vivienne Chuter is a Professor in the Department of Podiatry at Western Sydney University and Honarary Professor in the School of Health SCiences at The University of NewCastle. She is a member of the IWGDF. She has published extensively on diabetic foot disease and leads a clinically based research program focusing on prevention and management of diabetes-related foot disease for Aboriginal and Torres Strait Islander people and for non-Indigenous Australians.Dr. Nicolaas Schaper is emeritus professor of Endocrinology at Maastricht University Hospital in the Netherlands. Dr. Schaper was coordinator of the European diabetic foot research consortium, Eurodiale. He is Chair of the 2023 Diabetic Foot Symposium and is Chair of the IWGDF.Dr. Joseph L. Mills is a Professor of Vascular Surgery at Baylor in Houston, Texas. He is a member of the IWGDF. Dr. Mills is a leader in the vascular surgery global community, has served as president of the Peripheral Vascular Surgery Society and is currently a member of the Surgery Residency Review Committee of the ACGME.Further reading:The intersocietal IWGDF, ESVS, SVS guidelines on peripheral artery disease in people with diabetes mellitus and a foot ulcer.Global vascular guidelines for CLTIBest-CLIEngaging patients and caregivers to establish priorities for the management of diabetic foot ulcersA systematic review of multidisciplinary teams to reduce major amputations for patients with diabetic foot ulcersA vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisation procedure to restore limb perfusion (BASIL-2): an open-label, randomised, multicentre, phase 3 trialRelease of the National Scheme's Aboriginal and Torres Strait Islander Health and Cultural Safety Strategy 2020-2025; the impacts for podiatry in Australia: a commentaryESVS 2023 Clinical Practice Guidelines on Antithrombotic Therapy for Vascular DiseasesResults of the CAPRIE trial: efficacy and safety of clopidogrel. Clopidogrel versus aspirin in patients at risk of ischaemic eventsLow-Dose Aspirin for the Primary Prevention of Cardiovascular Disease in Diabetic Individuals: A Meta-Analysis of Randomized Control Trials and Trial Sequential Analysis*Diabetes, Lower-Extremity Amputation, and DeathHosts: Dr. Naveed A. Rahman is chief surgery resident at SUNY Upstate in Syracuse, NY. He will be pursuing vascular surgery fellowship at University of Maryland starting in 2024. His Doximity profile is www.doximity.com/pub/naveed-rahman-md. X: @naveedrahmanmdDr. Suzanne Stokmans is a 5th year vascular surgery resident in the Isala hospital in Zwolle, the Netherlands.Dr. Ezra Schwartz is a medical graduate from McGill University currently completing a Masters of Medical Science in Medical Eduation at Harvard Medical School. He is an aspiring vascular surgeon and surgical education researcher. X: @ezraschwartz10

Audible Bleeding editor Wen (@WenKawaji) is joined by second year medical student Nishi (@Nishi_Vootukuru), third year medical student Leana Dodge (@ldogbe4), JVS editor Dr. Forbes (@TL_Forbes) and JVS-VS associate editor Dr. Curci (@CurciAAA) to discuss two great articles in the JVS family of journals regarding Medicare reimbursement for complex endovascular aortic aneurysm repair and novel drug delivery method involving tissue factor targeting peptides in reducing vascular injury response. This episode hosts Dr.Brinster, Dr. Conte, and Dr. Kim, the authors of the following papers:   Articles:   Current Medicare reimbursement for complex endovascular aortic repair is inadequate based on results from a multi-institutional cost analysis by Brinster et al. Tissue factor targeting peptide enhances nanoparticle binding and delivery of a synthetic specialized pro-resolving lipid mediator to injured arteries by Dr. Levy et al.     Show Guests: Dr. Clayton Brinster:  Associate Professor of Surgery at University of Chicago, and Co-Director of Center for Aortic Diseases, Department of Vascular Surgery and Endovascular Therapy Dr. Michael Conte: E.J. Wylie Chair, professor and chief of the division of Vascular and Endovascular Surgery at UCSF. Co-Directot of Heart and Vascular Center, Co-Director of UCSF Center for Limb Preservation and Diabetic Foot. Dr. Alexander Kim: Vascular surgery fellow and research fellow at UCSF   Follow us @audiblebleeding Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey.  

Visit pointofcaremedicine.com to see the templates, pearls, literature, and other resources discussed in this episode. Our mission is to create accessible and easy-to-use digital resources that help healthcare professionals tackle common clinical presentations at the point of care without getting bogged down by unnecessary details or trivia. Timestamps 00:00:08 – Background 00:01:12 – Pathophysiology 00:01:55 – Admission Checklist 00:03:29 – HPI Intake 00:04:19 – To Note on Exam 00:04:58 – Plan: Workup 00:05:40 – Plan: Treatment 00:07:28 – If You Remember Nothing Else 00:08:28 – Pearls 00:10:43 – Literature Literature IWGDF/IDSA Guidelines on Diagnosis and Treatment of Diabetes-Related Foot Infections (Diabetes Metab Res Rev, 2023) Diabetic Foot Ulcers and Their Recurrence (NEJM, 2017) Diabetic Foot Ulcers: A Review (JAMA, 2023)

Links talked about: Cultural values: can they explain self-reported health? Incidence vs prevalence and the epidemiologist's bathtub A new declaration for feet's sake: Halving the global diabetic foot disease burden from 2% to 1% with next generation care Twitter thread on diabetic foot screening

Episode 155: Diabetic Foot Infection GuidelinesFuture Dr. Perez presents the updates on lung cancer screening by the American Cancer Society. Future Dr. Danusantoso explains the classification, diagnosis, and treatment of diabetic foot infections according to the guidelines published by the International Working Group on the Diabetic Foot (IWGDF). Dr. Arreaza adds comments and anecdotes.  You are listening to Rio Bravo qWeek Podcast, your weekly dose of knowledge brought to you by the Rio Bravo Family Medicine Residency Program from Bakersfield, California, a UCLA-affiliated program sponsored by Clinica Sierra Vista, Let Us Be Your Healthcare Home. This podcast was created for educational purposes only. Visit your primary care provider for additional medical advice.Intro: Lung cancer screening update.Written by Luz Perez, MSIII, Ross University School of Medicine. Editing by Hector Arreaza, MD.Hello, my name is Luz Perez and today I will talk about lung cancer screening.As a reminder, lung cancer is the top cause of cancer-related death in men and women worldwide. In the United States, lung cancer causes the death of about 154,000 people each year[4]. Smoking is the most significant risk factor for developing lung cancer, a risk that directly correlates to how much and how long a person has smoked[2]. Despite the efforts to decrease lung cancer-related deaths, which include screening of patients at risk and counseling on smoking cessation, many patients go undiagnosed in part because lung cancer can be asymptomatic but also because many people at risk did not meet the criteria for screening, according to previous guidelines… BUT On November 1, 2023, the American Cancer Society updated its guidelines for lung cancer screening to decrease mortality by lung cancer in the US. The updated lung cancer screening guidelines were published in November, which is Lung Cancer Awareness Month. This guideline aims to expand eligibility criteria for lung cancer screening. Previously, the guidelines covered people only between the ages of 55-74 who were current smokers or had quit within the past 15 years and had a 30 or more pack-year smoking history[3].The new guidelines recommend annual screening with low-dose CT (LDCT) scan for people who are 50-80 years old who are current or former smokers and who have a 20 or more pack-year of smoking history [1]. This change means that about 5 million people who would previously not qualify for screening are now eligible for this potentially lifesaving screening exam.Additionally, the American Cancer Society emphasizes the significance of shared decision-making between patients and healthcare providers on lung cancer screening and smoking cessation. This includes ways to help patients stop smoking by providing counseling and interventions including medications. For patients who are eligible for screening, having a full discussion of the lung cancer screening process including the purpose of the procedure, risks and benefits of low-dose CT, and recommendations from other organizations, is key in the shared decision-making process[1]. Perhaps, the most important step in the implementation of these new guidelines is ensuring that medical professionals talk to their patients about them and make them aware of the importance of screening for lung cancer. In this way, we can reduce mortality and other consequences of this devastating disease. Written by Maria Danusantoso, MSIV, Ross University School of Medicine. Editing by Hector Arreaza, MD.Update to Guidelines for Treatment of Diabetic Foot InfectionsIntroductionIn October 2023, the International Working Group on the Diabetic Foot (IWGDF) and the Infectious Disease Society of America (IDSA) collaborated and published an update to the 2019 guideline on the diagnosis and management of infections of the foot in persons with diabetes mellitus.The present guidelines include a list of 25 recommendations for diagnosis and management and clinically useful figures and tables including a treatment algorithm, a classification system for defining diabetic foot infections, and empirical antibiotic therapy according to clinical presentation and microbiological data.The goal of this episode is not to provide an exhaustive review of the updated guidelines and algorithms but to highlight what I believe are the most important recommendations. I hope this brief presentation is viewed as an introduction and that this encourages you, the listener, to independently read the guidelines in full and implement them into your own clinical practice.Wound Colonization Versus Wound InfectionBefore jumping into some of the recommendations, I want to take some time to discuss briefly how to classify diabetic foot infections. Most clinicians, including myself, will see a patient with diabetes with a foot ulcer or wound and want to treat it with antibiotics or admit the patient to the hospital. However, the updated guidelines propose that antibiotics and/or admission are not always indicated. For clinicians, there needs to be an awareness that wound colonization and wound infection are not the same. Wound colonization by bacteria is defined by the presence of bacteria on a wound surface without evidence of invasion of the host tissues. Colonization, then, can be considered a constant phenomenon as we live in a bacteria-filled world. Comment: If we culture our intact skin, we may find pathogens, that's why wound cultures even if they are positive, do not indicate there is infection. Tell us about infection.In contrast, wound infection is a disease state caused by the invasion and multiplication of microorganisms in host tissues that induce an inflammatory response in the host, usually followed by tissue damage. Therefore, since all wounds are colonized – often with potentially pathogenic microorganisms – we cannot define wound infection using only the results of wound cultures. Instead, diabetic foot infections are a clinical diagnosis based on the presence of manifestations of an inflammatory process involving a foot wound located below the malleoli. These signs and symptoms of inflammation may be masked in persons with diabetes especially if they have some level of baseline peripheral neuropathy, peripheral artery disease, or immune dysfunction.Classification of Diabetic Foot Infections.To assist with the classification of diabetic foot infections, the updated guidelines include a table for defining the presence and severity of an infection of the foot in a person with diabetes. Again, diabetic foot infections are a clinical diagnosis, and the clinical classification of infection can be described as: 1) uninfected, 2) mild, 3) moderate +/- O if osteomyelitis is present, 4) severe +/- O if osteomyelitis is present. Uninfected has no systemic or local symptoms or signs of infection. Mild infection is when at least two of the following are present: local swelling or induration, erythema between 0.5-2 cm around the wound in any direction, local tenderness or pain, local increased warmth, purulent discharge, and there is no other cause of an inflammatory response of the skin present (e.g., trauma, gout, acute Charcot neuro-arthropathy, fracture, thrombosis, or venous stasis).Moderate infection is without systemic manifestations and involves erythema extending 2 cm or more from the wound margin and/or involves tissue deeper than skin and subcutaneous tissues (e.g., tendon, muscle, joint, and bone) +/- the presence of osteomyelitis. The surrounding erythema and the depth of wound are key element in the classification of the wounds. Severe infection is associated with systemic manifestations and meets systemic inflammatory response syndrome (SIRS) criteria as manifested by 2 or more of the following: temperature below 36°C or above 38°C, heart rate greater than 90 beats per minute, respiratory rate greater than 20 breaths per minute, white blood cell count greater than 12,000/mm3 or greater than 10% immature (band) forms +/- presence of osteomyelitis. Features of Osteomyelitis on Plain X-RayWe have mentioned osteomyelitis quite a few times in this episode, so what are some ways we can diagnose osteomyelitis? Most commonly, osteomyelitis is diagnosed via imaging either with plain X-rays  or MRI. When looking at plain X-rays, there are a few features that are characteristic of diabetes-related osteomyelitis of the foot of which we should be aware regardless of our status as radiologists. Some of these features include bone sclerosis with or without erosion, abnormal soft tissue density or gas density in the subcutaneous fat, or new or evolving radiographic features on serial images spaced several weeks apart such as loss of bone cortex, focal demineralization, periosteal reaction or elevation. Changes in x-ray may be a late finding and indicate that the osteomyelitis is established.General Treatment Recommendations for Diabetic Foot InfectionsIn the updated guidelines, recommendation 11 states to not treat clinically uninfected foot ulcers with systemic or local antibiotic therapy when the goal is to reduce the risk of new infection or to promote ulcer healing. As previously said, diabetic foot infections are a clinical diagnosis. So if clinically the wound does not meet criteria to be classified as a mild, moderate, or severe infection, this recommendation proposes that no antibiotic treatment is the best treatment so as not to expose patients to potentially unnecessary and harmful treatment and to not promote antibiotic resistance in patients, which would potentially make treating diabetic foot infections more challenging in the future. We still want to very closely monitor the wound every 2-7 days and promote wound healing with pressure offloading, keeping the wound and the surrounding skin clean and dry, and other non-antibiotic management for local wound care.What are some common bacteria?.When it is indicated to treat diabetic foot infections per the guidelines, recommendation 14 states to target aerobic gram positive pathogens only for people with a mild diabetes related foot infection. These pathogens include beta hemolytic streptococci and Staphylococcus aureus including methicillin-resistant strains if indicated. Additionally, recommendation 15 advises not to empirically target antibiotic therapy against Pseudomonas aeruginosa in cases of diabetes-related foot infection in temperate climates. However, it is appropriate to use empirical treatment of P. aeruginosa if it has been isolated from cultures of the affected site within the previous few weeks or in a person with moderate or severe infection who resides in tropical/subtropical climates.Antibiotic Treatment Duration RecommendationThe final recommendation we have time to discuss in this episode is regarding antibiotic treatment duration. For mild infections, oral antibiotics (such as cephalexin or Bactrim) for a duration of 1-2 weeks is appropriate. However, if the infection is improving but is extensive and is resolving slower than expected or if the patient has severe peripheral artery disease, it is reasonable to consider extending treatment for up to 3-4 weeks.For moderate or severe infections without osteomyelitis, a total treatment duration of 2-4 weeks is recommended starting initially with IV antibiotics before transitioning to oral antibiotics. Antibiotic selection will depend on multiple factors, such as recent antibiotic use, or MRSA risk factors. For example, if the patient took antibiotics recently, they could receive Zosyn® and ceftriaxone. If osteomyelitis is present, antibiotic treatment duration can be anywhere from 2 days to 6 weeks depending on the amount of source control achieved. Ideally, we should wait to have bone resection before giving antibiotics, but we know that antibiotics are given promptly in the ER.In the cases of a resected infected bone or joint (when complete source control is achieved), a duration of 2-5 days is recommended, starting with IV antibiotics before transitioning to oral antibiotics. If there is minor amputation of the infected foot but there remains a positive wound culture or positive margins are seen on pathology (inflammatory cells are seen at the proximal margin of the amputated section), a 3-week antibiotic treatment duration is recommended, again starting with IV before transitioning to oral antibiotics.For diabetes-related foot osteomyelitis without bone resection or amputation, a 6-week course of antibiotics is recommended, again initially with IV antibiotics before transitioning to oral. In all the situations where there is a transition from IV to oral antibiotics, this transition may only occur once there are clinical signs of improvement, for example, improving erythema surrounding the wound, resolution of tenderness or purulent drainage, or SIRS criteria is no longer met.Summary: For more details regarding the 2023 update to the guidelines on the diagnosis and treatment of foot infection in persons with diabetes, please refer to the complete guidelines which can be accessed on the IWGDF Guidelines website and via the citations listed in the References. As a reminder, this podcast episode is not an exhaustive review of the guidelines, but, instead, a brief introduction to some of the recommendations. Thank you for listening and I hope you learned something new!_____________________________Conclusion: Now we conclude episode number 155 “Diabetic foot guidelines.” Future Dr. Perez started this episode with an introduction about the new guidelines to screen for lung cancer, then future Dr. Danusantoso gave an excellent summary about the classification and treatment of diabetic foot infections. Our patients with diabetes must have foot self-awareness and report any concerns to their family physicians or podiatrists so they can get prompt treatment.This week we thank Hector Arreaza, Luz Perez, and Maria Danusantoso. Audio editing by Adrianne Silva.Even without trying, every night you go to bed a little wiser. Thanks for listening to Rio Bravo qWeek Podcast. We want to hear from you, send us an email at RioBravoqWeek@clinicasierravista.org, or visit our website riobravofmrp.org/qweek. See you next week! _____________________References:McDowell, Sandy, New Lung Cancer Screening Guideline Increases Eligibility. American Cancer Society, published on November 1, 2023, Cancer.org. https://www.cancer.org/research/acs-research-news/new-lung-cancer-screening-guidelines-urge-more-to-get-ldct.htmlWolf AMD, Oeffinger KC, Shih TY, et al. Screening for lung cancer: 2023 guideline update from the American Cancer Society [published online ahead of print, 2023 Nov 1]. CA Cancer J Clin. 2023;10.3322/caac.21811. doi:10.3322/caac.21811. Link: https://pubmed.ncbi.nlm.nih.gov/37909877/Moniuszko, Sara. Lung cancer screening guidelines updates by American Cancer Society to include more people. CBS News, updated on November 3, 2023. https://www.cbsnews.com/news/lung-cancer-screening-guideline-american-cancer-society-update/Deffebach, M. E., & Humphrey, L. (2023). Screening for lung cancer. UpToDate. Retrieved November 6, 2023, UpToDate. https://www.uptodate.com/contents/screening-for-lung-cancerÉric Senneville, Zaina Albalawi, Suzanne A van Asten, Zulfiqarali G Abbas, Geneve Allison, Javier Aragón-Sánchez, John M Embil, Lawrence A Lavery, Majdi Alhasan, Orhan Oz, Ilker Uçkay, Vilma Urbančič-Rovan, Zhang-Rong Xu, Edgar J G Peters, IWGDF/IDSA Guidelines on the Diagnosis and Treatment of Diabetes-related Foot Infections (IWGDF/IDSA 2023), Clinical Infectious Diseases, 2023; ciad527, https://doi.org/10.1093/cid/ciad527Senneville, Éric et al. 2023. “IWGDF/IDSA Guidelines on the Diagnosis and Treatment of Foot Infection in Persons with Diabetes.” IWGDF Guidelines. Retrieved November 6, 2023 (https://iwgdfguidelines.org/wp-content/uploads/2023/07/IWGDF-2023-04-Infection-Guideline.pdf). Royalty-free music used for this episode: Gushito, “Gista Mista”, downloaded on November 16th, 2023, from https://www.videvo.net/ 

Dr. Richard L. Oehler, MD, Professor of Medicine at the USF Morsani College of Medicine, presents this update on Diabetic Foot Infections (DFIs). Focusing on recent guidelines updates from 2023, Dr. Oeher discusses DFI epidemiology, pathophysiology, and Diabetic foot exam basics. He then goes on to review diabetic vascular disease and its role in the progression of diabetic foot complications. Dr. Oehler then reviews the workup of diabetic foot infections including imaging and physical examination findings. Lastly, the management of diabetic foot osteomyelitis is discussed including treatment strategies and prevention.

11am-12pm Sports Review  Implementing the HSE Model of Care for the Diabetic Foot with community nurses Lost Lear opens in Town Hall Theatre, Galway on Wed 8 Nov    ‘Galway Talks with Keith Finnegan' broadcasts every weekday morning from 9am on Galway Bay FM

Join us in this compelling episode of "Life of Flow" as we delve into the world of vascular medicine with renowned experts, Dr. Andrea Casini and Dr. Giacomo Clerici. In "7 Years of Italian Arterializations," you'll witness their groundbreaking work and learn about their innovative techniques, challenges, and the impact they've made on the field. Patient stories, the future of vascular medicine, and their inspiring journeys await in this illuminating discussion. Discover the transformational power of arterialization and their unwavering commitment to medical innovation. Follow Life of Flow on Instagram Follow Life of Flow on Twitter Follow Dr. Miguel Montero-Baker on TwitterAbout Dr. Andrea Casini: Dr. Andrea Casini graduated in Medicine and Surgery in 1996 from the University of Milan with a specialization in Vascular Surgery.  Formerly, he served as the Head of the Vascular Surgery Division at the Center for the Care of Diabetic Foot at the Humanitas Gavazzeni Hospital in Bergamo. Today, he is the Director of the Vascular Surgery Unit at the San Carlo Clinic in Paderno Dugnano. His primary areas of interest include Carotid Surgery, Abdominal Aortic Surgery, and the treatment of diabetic foot conditions. He also has experience in endovascular treatment of arterial diseases, aneurysms, and carotid stenoses. Currently, he is a member of the Administrative Council of the IRCCS Carlo Besta Neurological Institute in Milan and CERISMAS - the Center for Research and Studies in Healthcare Management for Innovation in Healthcare Management Systems. Dr. Andrea Casini is also very active in producing scientific articles and texts, with his work appearing in prestigious medical journals. He has made numerous contributions during international conferences, particularly on the topic of diabetic foot care. About Dr. Giacomo Clerici: Dr. Cerici is a Graduate in Medicine and Surgery from the University of Pavia, specializing in Internal Medicine, with specialized training in Diabetic Foot Care. He was formerly affiliated with the Italian Diabetes Associations, SID, AMD, and The European Diabetic Foot Study Group (DFS) of EASD and is an accomplished author with numerous publications, including papers and chapters in international journals and books dedicated to Diabetic Foot Problems.  Dr. Clerici is actively involved in organizing several international wound care and Diabetic Foot (DF) meetings, such as WOUNDS at VEITHsymposium in the United States (www.veitsymposium.org), the Multidisciplinary International Limb and Amputation Prevention Conference (MILAN) in Europe, and the WINTER/SUMMER school of Diabetic Foot Surgery in Milan. He previously served as a co-program director of iLegx (www.ilegx.com). Currently, he holds the position of coordinator for diabetic foot centers in Italy.

A Guide to Seeing Them and Stopping Them in Their Tracks Be a step ahead of diabetic foot infections! Learn who really needs that MRI, when to call your vascular colleagues, and when you really need that pseudomonas and anaerobic coverage. We are joined by Dr. Andrew Webster, infectious disease physician and antimicrobial stewardship director at the Atlanta VA.  Emory Division of Infectious Diseases Claim free CME for this episode at curbsiders.vcuhealth.org! Patreon | Episodes | Subscribe | Spotify | YouTube | Newsletter | Contact | Swag! | CME Show Segments Intro Picks of the Week Case Definitions Risk Stratifications Diagnostic Work-up Vascular evaluations Treatment Outro Credits Writer, producer and show Notes: Reaford Blackburn, Jr., MD Cover Art and Infographic: Monee Amin, MD Hosts: Monee Amin, MD and Meredith Trubitt, MD    Reviewer:  Sai Achi, MD Showrunners: Matthew Watto MD, FACP; Paul Williams MD, FACP Technical Production: PodPaste Guest: Dr. Andrew Webster Sponsor: Green Chef Go to GreenChef.com/60curb and use code 60curb to get 60% off plus free shipping. Sponsor: Pathway Download the Pathway app today by visiting pathway.md Sponsor: Birch Living  Birch is giving 20% off ALL mattresses and 2 free eco-rest pillows at BirchLiving.com/curb when you use code BIRCHPARTNER20 Sponsor: Locumstory Get a comprehensive view of locums at locumstory.com Full transcript available HERE

At ADA 2023, hosts sit down with Gary Rothenberg, DPM, to discuss awareness and management of diabetic foot ulcers as well as how social determinants of health can influence risk and outcomes for patients with diabetes. Video version: https://www.hcplive.com/view/diabetes-dialogue-diabetic-foot-ulcers-and-social-determinants-of-health 

Editor's Summary by Anne Rentoumis Cappola, MD, ScM, Associate Editor of JAMA, the Journal of the American Medical Association, for the July 3, 2023, issue. Related Content: Audio Highlights

Wounds Editorial Board Member Dr. Stephen Bergquist interviews Dr. Eric J. Lullove about his original research, “Final Efficacy and Cost Analysis of a Fish Skin Graft vs Standard of Care in the Management of Chronic Diabetic Foot Ulcers: A Prospective, Multicenter, Randomized Controlled Clinical Trial.” Support for this content was provided by Kerecis.

A fascinating discussion of the current management of diabetic foot ulcers. Learn how the introduction of new protocols has decreased the rate of Amputation in Hospital Agostinho Neto. This conversation dives deeper into the needs for rehabilitation and he plight of Amputees in Cabo Verde and the overall challenges of vascular surgery practice in Cabo Verde

Link to bioRxiv paper: http://biorxiv.org/cgi/content/short/2023.02.16.528839v1?rss=1 Authors: Sandoval-Schaefer, T., Phan, Q., Dash, B., Prassinos, A., Duan, K., Gazes, M. I., Vyce, S. D., Hsai, H. C., Driskell, R., Horsley, V. Abstract: Wound repair requires the coordination of multiple cell types including immune cells and tissue resident cells to coordinate healing and return of tissue function. Diabetic foot ulceration is a type of chronic wound that impacts over 4 million patients in the US and over 7 million worldwide (Edmonds et al., 2021). Yet, the cellular and molecular mechanisms that go awry in these wounds are not fully understood. Here, by profiling chronic foot ulcers from non-diabetic (NDFUs) and diabetic (DFUs) patients using single-cell RNA sequencing, we find that DFUs display transcription changes that implicate reduced keratinocyte differentiation, altered fibroblast function and lineages, and defects in macrophage metabolism, inflammation, and ECM production compared to NDFUs. Furthermore, analysis of cellular interactions reveals major alterations in several signaling pathways that are altered in DFUs. These data provide a view of the mechanisms by which diabetes alters healing of foot ulcers and may provide therapeutic avenues for DFU treatments. Copy rights belong to original authors. Visit the link for more info Podcast created by Paper Player, LLC

In this podcast, Kazem Kazempour, PhD, and Kush Dhody, MD, discuss how careful study design is required to demonstrate efficacy of new wound healing treatments.

Interview with vascular surgeon Palma Shaw, MD

Since November 14th is World Diabetes Day, hosts Kym McNicholas and Dr. Phillips are joined by guest co-hosts Podiatrist Dr. David Alper and Nurse Practitioner Kay Smith, to talk about one of the most prevalent complications of Diabetes, amputation. Every 20 seconds globally, a limb is amputated due to diabetes. Why? Extra sugar in the blood can damage the artery walls, allowing for fats and cholesterol to sneak in and push the artery wall out, hindering blood flow to the feet. Sometimes the first sign a diabetic has restricted blood flow in the leg arteries, known as Peripheral Artery Disease (P.A.D.) is when an ulcer appears on their foot or toe that won't heal. Every 1.2 seconds somewhere in the world there is a new diabetic foot ulcer that appears on someone. Diabetic Foot Ulcers are responsible for more hospitalizations than any other complication of diabetes, driving direct costs through the roof. Innovators at Sensoria® Health and Defender believe they have one way to help heal diabetic wounds faster, minimize related amputations, and reduce costs. Dr. Jason Hanft, podiatrist, and Michael DiTullo, a former shoe developer at Nike, have created the Foot Defender® to help patients expedite the healing time for their diabetic ulcers. The Foot Defender is designed to help heal diabetic foot ulcers and reduce the risk of amputations by improving patient adherence to mechanical offloading, monitoring patient usage, activity, improving outcomes, and reducing healthcare costs. A patient supported by P.A.D. advocacy organization The Way To My Heart shares his long journey trying to save his legs from amputation as well as his feedback after trying out The Foot Defender® for a few weeks.

In this episode of The PODdoctors podcast, Dr. Damien Dauphinee, a board-certified foot and ankle surgeon, and Dr. Raafae Hussain, fellowship trained foot and ankle surgeon, talk about the common chronic wounds or ulcers they see every day, particularly diabetic foot ulcers, and how to treat them.“Probably the most common that we'll see is your neuropathic, aka your diabetic, foot ulcer. This is when you have uncontrolled diabetes, you have that neuropathy, you have that poor healing potential, and they end up walking until they get a sore, typically on the bottom of their foot, on a high-pressure spot. These are things we're able to take care of if we stay ahead of it.” - Dr. Raafae Hussain [04:51]“It's probably more important to get rid of the dead tissue, the broken-down collagen in the wound bed, than it is to use a silver dressing to prevent infection.” - Dr. Damien Dauphinee [18:23]“Every day a wound is open, especially in diabetic patients, is another chance for that to get infected. So, we really need to use whatever advanced therapy that we can get ahold of to get that wound closed rapidly because the expenses in these wounds are not in the stuff we're using to treat them. The expensive stuff is the amputation, the six weeks of antibiotics, the 3-4 trips to the hospital.” - Dr. Damien Dauphinee [22:40]Top Takeaways:4 major types of chronic wounds Methods of treating and dressing diabetic foot ulcersSantyl vs. Silver dressings: Which is better?How to offload diabetic foot ulcers to facilitate healingCan you reverse neuropathy in diabetic patients?Treating vascular and venous issues in patients with foot ulcersKey methods and biologics used in treating chronic woundsWhat You Will Learn:[00:39] Intro[02:07] Common wounds we see on a daily basis & Their causes[07:56] Diagnosing and treating ulcers on the feet[15:19] Dressing foot ulcers after the first treatment[23:33] Offloading diabetic foot ulcers[26:47] Important data & statistics on diabetic foot ulcers[28:46] Why podiatrists work with vascular specialists[36:04] Using hyperbaric oxygen therapy and NPWT to heal wounds[46:33] Biologics used for treating wounds[52:19] Important takeaways on chronic wounds in diabetic patients[57:23] Breaking down a few of Dr. Dauphinee's past chronic wound casesResources:Visit our website: https://thepoddoctors.comBook Mentioned: Saving Limbs, Saving Lives: Advanced Treatments for Preventing Amputations in Diabetic Populations by Dr. Damien DauphineeLearn more about the Wise Healing Center in Argyle, TX: https://www.wisehealthsystem.com/location/wise-healing-center-argyle

In this episode, we review the high-yield topic of Diabetic Foot Ulcers from the Foot & Ankle section. Follow Orthobullets on Social Media: Facebook: www.facebook.com/orthobullets Instagram: www.instagram.com/orthobulletsofficial Twitter: www.twitter.com/orthobullets LinkedIn: www.linkedin.com/company/27125689 YouTube: www.youtube.com/channel/UCMZSlD9OhkFG2t25oM14FvQ --- Send in a voice message: https://anchor.fm/orthobullets/message

Richard Hague is the CEO and President of PolarityTE, creating a paste-like substance containing multicellular skin segments that can be spread on the patient's wound bed and engrafts into the wound. This stimulates healing from the inside out with wounds created by diabetic foot ulcer and venous leg ulcer. Richard elaborates, "We're very excited about our SkinTE platform. It's a very unique and novel approach for treating wounds. The goal here is to use the patient's own cells so that there's no risk of rejection of any kind, no introduction of anything foreign to the body." "The first thing that happens is a physician takes a very small, full thickness harvest from the patient's body, usually somewhere in the proximal calf area. So this is healthy tissue. It's a small harvest that's easily stitched up and closed. And that tissue is sent back to our facility in Salt Lake City. We have a proprietary process for processing that skin that allows us to utilize all aspects of that harvest. So we're using all layers of the cells and all the extracellular material that's in that full thickness skin." @PolarityTE #PolarityTE #SkinTE #DiabeticFootUlcers #Diabetes #PressureUlcers PolarityTE.com Listen to the podcast here

Richard Hague is the CEO and President of PolarityTE, creating a paste-like substance containing multicellular skin segments that can be spread on the patient's wound bed and engrafts into the wound. This stimulates healing from the inside out with wounds created by diabetic foot ulcer and venous leg ulcer. Richard elaborates, "We're very excited about our SkinTE platform. It's a very unique and novel approach for treating wounds. The goal here is to use the patient's own cells so that there's no risk of rejection of any kind, no introduction of anything foreign to the body." "The first thing that happens is a physician takes a very small, full thickness harvest from the patient's body, usually somewhere in the proximal calf area. So this is healthy tissue. It's a small harvest that's easily stitched up and closed. And that tissue is sent back to our facility in Salt Lake City. We have a proprietary process for processing that skin that allows us to utilize all aspects of that harvest. So we're using all layers of the cells and all the extracellular material that's in that full thickness skin." @PolarityTE #PolarityTE #SkinTE #DiabeticFootUlcers #Diabetes #PressureUlcers PolarityTE.com Download the transcript here

This episode covers what we need to know about the diabetic foot - a favourite topic for the general surgical exam. - background- pathophysiology - workup and important factors to consider- classification systems - management - some information about charcot neuroarthropathy DisclaimerThe information in this podcast is intended as a revision aid for the purposes of the General Surgery Fellowship Exam.This information is not to be considered to include any recommendations or medical advice by the author or publisher or any other person. The listener should conduct and rely upon their own independent analysis of the information in this document.The author provides no guarantees or assurances in relation to any connection between the content of this podcast and the general surgical fellowship exam.  No responsibility or liability is accepted by the author in relation to the performance of any person in the exam.  This podcast is not a substitute for candidates undertaking their own preparations for the exam.To the maximum extent permitted by law, no responsibility or liability is accepted by the author or publisher or any other person as to the adequacy, accuracy, correctness, completeness or reasonableness of this information, including any statements or information provided by third parties and reproduced or referred to in this document. To the maximum extent permitted by law, no responsibility for any errors in or omissions from this document, whether arising out of negligence or otherwise, is accepted.The information contained in this podcast has not been independently verified.© Amanda Nikolic 2022

In this episode, Yogi and Sam provide an overview into foot disorders within diabetic patients.

In this episode, Dr. Adam Silverman, DPM talks about how he was taught wound care at podiatry school, and how that set him up to treat patients with diabetic foot ulcers. He also tells us more about his favorite way to treat these conditions, called specialized casting. *The information stated on the podcast is for educational purposes only and does not substitute for professional medical advice. We strongly recommend consulting a medical professional or healthcare provider if you are seeking medical advice, diagnoses, or treatment.

MED Nation invited Dr. Monika Singh, MD, to discuss eye health. This episode covers diabetic eye health, LASIK eye surgery, and the difference between a medical ophthalmologist and a comprehensive ophthalmologist. 

In this podcast, Kazem Kazempour, PhD, and Kush Dhody, MD, discuss how careful study design is required to demonstrate efficacy of new wound healing treatments.

This episode discusses discussing how VA is working to reduce leg amputations by leveraging technology to help prevent diabetic foot ulcers.

Stand up for your feet. That is the message from David Armstrong, DPM, Ph.D., a member of the Society for Vascular Surgery and a podiatric surgeon. To keep feet healthy, Dr. Armstrong recommends people look at their feet daily or have someone do it for them. Check for ulcers or wounds, for redness, swelling, or an ingrown toenail, as well as any wound bleeding into the sock. He joins us today to talk about foot health, diabetes, and more.Dr. Armstrong is a Professor of Surgery at the Keck School of Medicine at the University of Southern California and co-director of the USC Limb Preservation Program. He has produced more than 510 peer-reviewed research papers in dozens of medical journals as well as over 90 book chapters, is co-editor of the American Diabetes Association's Clinical Care of the Diabetic Foot, now in its third edition, and was the first podiatric surgeon to become a member of the Society of Vascular Surgery.Want better health and nutrition? Now you can get personalized supplement recommendations and custom vitamin packs delivered to your door! Go to PersonaNutrition.com/Roizen and take your free assessment and get 50% off your order today. - sponsor  BonusHow Your Diet Affects Your Risk for Cancer

The AOFAS Young Physicians Committee is re-releasing the Resident Series which is intended to assist Residents in prep for Clinic, the OR, Board Review, and the OITE. In this episode Dr. Justin Tsai covers diagnosis, classification schemes, and management of Charcot Arthropathy and Diabetic Foot Ulcers. For additional educational resources visit https://www.aofas.org/ Thank you to Bioventus for sponsoring this episode. For more information, visit: https://www.exogen.com/radio/

Weather warming up/changing/how that affects feet and footwear, diabetes, activities, etc.

Dr. Richard Oehler, Professor of Medicine at the Division of Infectious Diseases, Morsani College of Medicine, presents an update in the management of diabetic foot infections for the 2020s. Dr. Oehler begins by introducing the concept of a multidisciplinary team as essential to the management of these patients. He then describes the current epidemiology of diabetes and diabetic foot ulcers. He also discusses Charcot arthropathy and how it occurs. Annual diabetic foot exams are also crucial to these patients, and Dr. Oehler also reviews proper techniques and what to ask/examine. Some of the newer hypotheses about the importance of biofilms to the creation and persistence of diabetic foot wounds are also presented. He also covers diabetic peripheral vascular disease, diagnostic imaging modalities, wound management, and the proper empiric antibiotic regimens and durations of therapy. Lastly, he discusses prevention techniques necessary to avoid recurrent ulceration.

Listen to Professor Paul Chadwick talk about the role a patient play in the care of diabetic foot ulcer and how to empower them. Learn more The views, information, and/or opinions expressed in this podcast are solely those of the individuals involved and do not necessarily represent those of Mölnlycke Health Care (“Mölnlycke”). Mölnlycke is not responsible and does not verify the accuracy of any of the information contained in this podcast. The information presented is solely for informational and educational purposes. The presentation may contain information on Mölnlycke's products, educational content and/or demonstrate certain techniques used by the guest speaker. However, Mölnlycke does not provide any medical advice and this podcast shall thus not be perceived as a medical advice.  Promotion of Mölnlycke's products is to be on-label and consistent with approved indications and intended uses. For detailed device information, including indications for use, contraindications, effects, precautions and warnings, please consult the product's Instructions for Use (IFU) prior to use. This presentation and the information presented may not be appropriate for all jurisdictions. The guest(s) are paid consultants of Mölnlycke.

In this episode of The PODdoctors podcast, Dr. Damien Dauphinee, a board-certified foot and ankle surgeon, and Dr. Raafae Hussain, Fellowship trained foot and ankle surgeon, talk about the foot-related complications associated with diabetes, including diabetic foot ulcers. They also discuss the treatment options to prevent amputation and why it's important to decrease the pressure off an ulcer to help it heal.   “It's really hard to rationalize spending tens of thousands of dollars on wound healing technology, amniotic tissue, growth factors and surgeries when someone's not going to stop smoking.” -Dr. Damien Dauphinee [05:06]   Top Takeaways: Learn ways to prevent amputations from diabetes issues Learn how smoking can raise the risk of peripheral artery disease (PAD) Learn how hyperbaric medicine and vacuum-assisted closure (VAC) improve wound healing capacity Learn about amniotic and stem cell therapy   What You Will Learn: [00:44] Intro [01:22] What they can do to prevent amputations and how stents have evolved [04:41] How smoking can raise the risk of PAD [06:05] What is hyperbaric medicine and other methods to improve wound healing [09:58] What is a wound VAC [12:09] How moisture balanced wound healing is the goal [14:45] How are amniotic or placental tissues used in wound care [18:08] Some important stats about diabetic foot problems   Resources: Visit our website: https://thepoddoctors.com/ Book Mentioned: Saving Limbs, Saving Lives: Advanced Treatments for Preventing Amputations in Diabetic Populations by Dr. Damien Dauphinee

Learn to manage a common infectious disease scenarios. This podcast takes you through the clinical presentation and appropriate history and physical, as well as management of diabetic foot infections based on the most recent IDSA guidelines. 

Dr. Jessica Davis // Orthopedic Tuesdays // www.ptonice.com